Page last updated: 2024-09-04

tipifarnib and oblimersen

tipifarnib has been researched along with oblimersen in 2 studies

Compound Research Comparison

Studies (tipifarnib)	Trials (tipifarnib)	Recent Studies (post-2010) (tipifarnib)	Studies (oblimersen)	Trials (oblimersen)	Recent Studies (post-2010) (oblimersen)
309	92	94	195	40	27

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Tauchi, T	1
Grever, MR	1

Reviews

2 review(s) available for tipifarnib and oblimersen

Article	Year
[Molecular pathogenesis of chronic myeloid leukemia and tyrosine kinase inhibitor]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2004, Volume: 45, Issue:1 Topics: Animals; Benzamides; Chromosome Aberrations; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Piperidines; Pyridines; Pyrimidines; Quinolones; Randomized Controlled Trials as Topic; Thionucleotides	2004
New drugs in acute myeloid leukemia. Clinical advances in hematology & oncology : H&O, 2003, Volume: 1, Issue:8 Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Evaluation; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Imatinib Mesylate; Leukemia, Myeloid; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Quinolones; Thionucleotides	2003

Article

Year

[Molecular pathogenesis of chronic myeloid leukemia and tyrosine kinase inhibitor].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2004, Volume: 45, Issue:1

Topics: Animals; Benzamides; Chromosome Aberrations; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Piperidines; Pyridines; Pyrimidines; Quinolones; Randomized Controlled Trials as Topic; Thionucleotides

2004

New drugs in acute myeloid leukemia.

Clinical advances in hematology & oncology : H&O, 2003, Volume: 1, Issue:8

Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Evaluation; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Imatinib Mesylate; Leukemia, Myeloid; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Quinolones; Thionucleotides

2003